QCM
AMRX icon

Quantinno Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Quantinno Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62M Buy
209,030
+171,431
+456% +$2.35M ﹤0.01% 1497
2026
Q1 		$467K Buy
37,599
+10,457
+39% +$140K ﹤0.01% 2759
2025
Q4 		$342K Buy
27,142
+4,460
+20% +$51K ﹤0.01% 2744
2025
Q3 		$227K Buy
22,682
+9,583
+73% +$86K ﹤0.01% 2675
2025
Q2 		$106K Buy
+13,099
New +$98.8K ﹤0.01% 2503

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Quantinno Capital Management's AMRX Position: Q2 2026 in Review

Quantinno Capital Management increased its Amneal Pharmaceuticals (AMRX) stake by 456% in Q2 2026, buying an estimated $2.35M and bringing the position to 209,030 shares worth $3.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

Quantinno Capital Management first reported a position in AMRX in Q2 2025 and has held it in 5 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Quantinno Capital Management held 209,030 shares of Amneal Pharmaceuticals worth $3.62M as of Q2 2026.
  • Quantinno Capital Management bought 171,431 Amneal Pharmaceuticals shares in Q2 2026, an estimated $2.35M.
  • Amneal Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1497 holding.
  • Quantinno Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.